Opicinumab: is it a potential treatment for multiple sclerosis?
- PMID: 32793736
- PMCID: PMC7396746
- DOI: 10.21037/atm.2020.03.131
Opicinumab: is it a potential treatment for multiple sclerosis?
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.03.131). The authors have no conflicts of interest to declare.
Comment on
-
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.Lancet Neurol. 2019 Sep;18(9):845-856. doi: 10.1016/S1474-4422(19)30137-1. Epub 2019 Jul 5. Lancet Neurol. 2019. PMID: 31285147 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources